Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Short term Debt (2016 - 2022)

Historic Short term Debt for Fennec Pharmaceuticals (FENC) over the last 8 years, with Q2 2022 value amounting to $1.0 million.

  • Fennec Pharmaceuticals' Short term Debt changed N/A to $1.0 million in Q2 2022 from the same period last year, while for Jun 2022 it was $1.0 million, marking a year-over-year change of. This contributed to the annual value of $167.0 million for FY2017, which is 50596060.61% up from last year.
  • Latest data reveals that Fennec Pharmaceuticals reported Short term Debt of $1.0 million as of Q2 2022.
  • Fennec Pharmaceuticals' 5-year Short term Debt high stood at $1.0 million for Q2 2022, and its period low was $500000.0 during Q1 2022.